HCR Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-277
| Closed | -$291K | – | 237 |
|
|
2024
Q3 | $291K | Hold |
277
| – | – | 0.04% | 180 |
|
|
2024
Q2 | $291K | Hold |
277
| – | – | 0.04% | 176 |
|
|
2024
Q1 | $267K | Sell |
277
-5
| -2% | -$4.81K | 0.04% | 181 |
|
|
2023
Q4 | $248K | Buy |
282
+37
| +15% | +$32.5K | 0.04% | 171 |
|
|
2023
Q3 | $202K | Buy |
+245
| New | +$202K | 0.04% | 163 |
|
|
2023
Q2 | – | Sell |
-250
| Closed | -$205K | – | 183 |
|
|
2023
Q1 | $205K | Buy |
+250
| New | +$205K | 0.04% | 164 |
|
|
2022
Q2 | – | Sell |
-310
| Closed | -$217K | – | 195 |
|
|
2022
Q1 | $217K | Buy |
+310
| New | +$217K | 0.04% | 176 |
|
|
2020
Q4 | – | Sell |
-408
| Closed | -$228K | – | 275 |
|
|
2020
Q3 | $228K | Buy |
+408
| New | +$228K | 0.05% | 149 |
|